Skip to main content
. 2019 Jan 29;69(679):e134–e145. doi: 10.3399/bjgp19X701009

Table 1.

Participant characteristics (n = 35)

Diagnosis (patient identification) Patients (relatives),an Females, n Males, n Age, years Duration of appraisal and help-seeking interval, monthsb,c Duration of diagnostic interval, monthsc,d
Median (range) Median (range) Median (range)
Non-Hodgkin lymphoma
  Diffuse large B-cell
  (P2, 4, 8, 9, 20, 21, 24, 27, 29, 31, 32, 35)
12 (7) 5 7 64 (48–81) 1 (0.5–13) 2.5 (1–14)
  Follicular
   (P1, 3, 6, 10, 12, 13, 18, 22, 26)
9 (2) 4 5 63 (39–84) 1 (0.5–12) 3 (1.5–15)
  Marginal zone
   (P5, 16, 25, 28, 30, 33)
6 (1) 4 2 62 (57–76) 1 (0.5–10) 12 (3–25)
  Mantle cell
   (P11, 15, 34)
3 (3) 2 1 71 (70–75) 1 (1–6) 2 (2–10)
Hodgkin lymphoma
(P7, 14, 17, 19, 23)
5 (2) 2 3 36 (23–56) 0.5 (0.5–2) 5 (3–24)
Total 35 (15) 17 18 63 (23–84) 1 (0.5–13) 4 (1–24)
a

All were spouses and/or partners of the interviewee with lymphoma.

b

First symptom to first help seeking.

c

Estimate based on information provided by patients in the routine Haematological Malignancy Research Network (HMRN) questionnaire about symptoms and help seeking.

d

First help seeking to diagnosis. P = participant.